Functional region mapping of HIV-2 Vpx protein

Microbes and Infection

Volumn 10, Issue 12-13, 2008, Pages 1387-1392

  Fujita, Mikako ^a   Otsuka, Masami ^a   Nomaguchi, Masako ^b   Adachi, Akio ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

HIV 2; Lymphocyte; Macrophage; Proline stretch; Vpx

Indexed keywords

PROLINE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; LYMPHOCYTE; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS;

ANIMALS; CELL LINE; HIV-2; HUMANS; LYMPHOCYTES; MACROPHAGES; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROLINE; TRANSFECTION; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 54849413779     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.08.005     Document Type: Article

References (21)

1. SM. EMBO J. 15 (1996) 6155-6165
2. Pancio H.A., Heyden N.V., and Ratner L. The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J. Virol. 74 (2000) 6162-6167
3. Ueno F., Shiota H., Miyaura M., Yoshida A., Sakurai A., Tatsuki J., Koyama A.H., Akari H., Adachi A., and Fujita M. Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5 (2003) 387-395
4. Fujita M., Otsuka M., Miyoshi M., Khamsri B., Nomaguchi M., and Adachi A. Vpx is critical for the reverse transcription of human immunodeficiency virus type 2 genome in macrophages. J. Virol. 82 (2008) 7752-7756
5. Guyader M., Emerman M., Montagnier L., and Peden K. Vpx mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J. 8 (1989) 1169-1175
6. Kawamura M., Sakai H., and Adachi A. Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells. Microbiol. Immunol. 38 (1994) 871-878
7. Lebkowski J.S., Clancy S., and Calos M.P. Simian virus 40 replication in adeno-virus-transformed human cells antagonizes gene expression. Nature 317 (1985) 169-171
8. Akari H., Fukumori T., Iida S., and Adachi A. Induction of apoptosis in Herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86. Biochem. Biophys. Res. Commun. 263 (1999) 352-356
9. +T lymphocytes in cynomolgus macaques. Clin. Immunol. 91 (1999) 321-329
10. Fujita M., Sakurai A., Yoshida A., Miyaura M., Koyama A.H., Sakai K., and Adachi A. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodefiociency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif. J. Virol. 77 (2003) 1626-1632
11. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
12. Koh K.B., Fujita M., and Adachi A. Elimination of HIV-1 plasmid DNA from virus samples obtained from transfection by calcium-phosphate co-precipitation. J. Virol. Methods 90 (2000) 99-102
13. Willey R.L., Smith D.H., Lasky L.A., Theodore T.S., Earl P.L., Moss B., Capon D.J., and Martin M.A. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62 (1988) 139-147
14. Adachi A., Miyaura M., Sakurai A., Yoshida A., Koyama A.H., and Fujita M. Growth characteristics of SHIV without the vpu gene. Int. J. Mol. Med. 8 (2001) 641-644
15. MAC gag capsid region. J. Virol. 75 (2001) 10527-10531
16. Fujita M., Yoshida A., Sakurai A., Tatsuki J., Ueno F., Akari H., and Adachi A. Susceptibility of HVS-immortalized lymphocytic HSC-F cells to various strains and mutants of HIV/SIV. Int. J. Mol. Med. 11 (2003) 641-644
17. Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., Fujita M., Uchiyama T., and Adachi A. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 16959-16964
18. SM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 4 (2007) 2
19. Srivastava S., Swanson S.K., Manel N., Florens L., Washburn M.P., and Skowronski J. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for Cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4 (2008) e1000059
20. Sharova N., Wu Y., Zhu X., Stranska R., Kaushik R., Sharkey M., and Stevenson M. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4 (2008) e1000057
21. Khamsri B., Murao F., Yoshida A., Sakurai A., Uchiyama T., Shirai H., Matsuo Y., Fujita M., and Adachi A. Comparative study on the structure and cytopathogenic activity of HIV Vpr/Vpx proteins. Microbes Infect. 8 (2006) 10-15